ALC:NYSE
Alcon
76,55 $
arrow_downward
-1,05%(-0,81) 1D
5 նոյ, 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
77,17 $
High
77,82 $
Low
76,18 $
Mkt. cap
31,23 մլրդ
Avg. vol.
1,80 մլն
Volume
2,12 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
Open
77,17 $
High
77,82 $
Low
76,18 $
Mkt. cap
31,23 մլրդ
Avg. vol.
1,80 մլն
Volume
2,12 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
Yahoo Finance
·
8 ժամ առաջ
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks
·
8 ժամ առաջ
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Yahoo Finance
·
9 ժամ առաջ
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
SectorHealth Care
Industry-
Websitealcon.com